The company said sales for Q3 2025 were $4.7 billion, up 6.1% from the prior-year period, and up 5.4% on a daily, constant currency basis. It said gross profit margin was 38.6%, down 60 basis points.

1. 01

   The company said sales for Q3 2025 were $4.7 billion, up 6.1% from the prior-year period, and up 5.4% on a daily, constant currency basis. It said gross profit margin was 38.6%, down 60 basis points.

2. 02

   The company said its operating margin was 11.0%, down 460 basis points from a year earlier, due to a non-cash loss related to its planned exit from the U.K. market and the Cromwell divestiture. Excluding that loss, it said adjusted operating margin was 15.2%, down 40 basis points.

3. 03

   The company said diluted earnings per share for Q3 were $6.12 on a reported basis, down 38.0%, and $10.21 on an adjusted basis, up 3.4%. It said operating cash flow was $597 million, capital expenditures were $258 million, and free cash flow was $339 million.

4. 04

   The company said it adjusted its full-year 2025 adjusted diluted EPS outlook to $39.00 to $39.75 from $38.50 to $40.25, and its sales outlook to $17.8 to $18.0 billion from $17.9 to $18.2 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.